Skip directly to search
Skip directly to A to Z list
Skip directly to navigation
Skip directly to page options
Skip directly to site content
Start of Search Controls
Search Form Controls
Search The CDC
submit
CDC A-Z Index
MENU
CDC A-Z
SEARCH
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Search Form Controls
Search The CDC
submit
CDC A-Z Index
Public Health Genomics and Precision Health Knowledge Base (v9.0)
PHGKB
About
Public Health Genomics Branch
PHGKB Weekly Horizon Scan
Genomics Precision Health Scan
Advanced Molecular Detection Clips
Non-Genomics Precision Health Scan
CDC-authored Publications Scan
Specialized PHGKB
Cancer PHGKB
Diabetes PHGKB
Economic Evaluation PHGKB
Environmental Health PHGKB
Family Health History PHGKB
Health Equity PHGKB
HLBS-PopOmics
Infectious Diseases PHGKB
Implementation Science PHGKB
Neurological Disorders PHGKB
Pharmacogenomics PHGKB
Primary Immune Deficiency Diseases PHGKB
Rare Diseases PHGKB
Reproductive and Child Health PHGKB
All Databases
COVID-19 GPH (47426)
CDC/NIH Web Information Database (32208)
CDC-Authored Genomics and Precision Health Publications Database (6104)
Precision Health Database (63914)
Tier-Classified Guidelines Database (535)
Pathogen Advanced Molecular Detection Database (26916)
All of Us Reports and Publications Database (730)
Human Genome Epidemiology
Human Genome Epidemiology Literature Finder (227373)
Epigenetic Epidemiology Publications Database (22897)
Release Note
Contact Us
Precision Health Database
Precision Health Database|Search|Public Health Genomics and Precision Health Knowledge Base (PHGKB)
Cancer
Last data update: May 21, 2024
. (Total: 63914 Documents since 2012)
All
Cancer
Diabetes
Economic
Equity
Environmental
FHH
HLBS
ID
Implementation
ND
PGx
PI
Rare
RCH
dataset
All
GPH
Non-GPH
Filtered By
:
Select to fine-tune your search
Disease
Gene
Product Type
Category
Year
Previous
Records 1 - 30 (of 2020 Records)
Next
Query Trace:
Ovarian cancer: identifying and managing familial and genetic risk-summary of new NICE guidance.
Eric Slade et al. BMJ 2024 385q807
Similar articles in PubMed
Targeted sequencing for hereditary breast and ovarian cancer in BRCA1/2-negative families from the Lynch Memorial Biobank reveals complex genetic architecture and phenocopies.
Jocelyn N Plowman et al. HGG Adv 2024 100306
Similar articles in PubMed
Clinical and genomic landscape of RAS mutations in gynecologic cancers.
Ji Son et al. Clin Cancer Res 2024
Similar articles in PubMed
Long-term oncologic outcomes of unselected triple-negative breast cancer patients according to BRCA1/2 mutations.
Woong Ki Park et al. NPJ Precis Oncol 2024 8(1) 96
Similar articles in PubMed
Walking the tightrope: Fertility preservation among hereditary breast and ovarian Cancer syndrome Previvors.
Sharonne Holtzman et al. Gynecol Oncol 2024 186176-181
Similar articles in PubMed
Eating Behaviors and Physical Activity versus the Big Five Personality Traits in Women with a Hereditary Predisposition to Breast or Ovarian Cancer.
Beata Pieta et al. Nutrients 2024 16(8)
Similar articles in PubMed
ChatGPT accurately performs genetic counseling for gynecologic cancers.
Jharna M Patel et al. Gynecol Oncol 2024 183115-119
Similar articles in PubMed
Psychosocial barriers and facilitators for cascade genetic testing in hereditary breast and ovarian cancer: a scoping review.
Agani Afaya et al. Fam Cancer 2024
Similar articles in PubMed
Role of Breast Cancer Risk Estimation Models to Identify Women Eligible for Genetic Testing and Risk-Reducing Surgery.
Azzurra Irelli et al. Biomedicines 2024 12(4)
Similar articles in PubMed
No Racial Disparities Observed Using Point-of-Care Genetic Counseling and Testing for Endometrial and Ovarian Cancer in a Diverse Patient Population: A Retrospective Cohort Study.
Michael Kim et al. Cancers (Basel) 2024 16(8)
Similar articles in PubMed
A Study on the Retrospective Reinterpretation of BRCA1 and BRCA2 Variants.
Jin Ju Kim et al. Clin Lab 2024 70(4)
Similar articles in PubMed
Cost-effectiveness of BRCA1 testing at time of obstetrical prenatal carrier screening for cancer prevention.
Shayan M Dioun et al. Am J Obstet Gynecol 2024
Similar articles in PubMed
Uptake of Risk-Reducing Measures, Cascade Testing, and Related Challenges Among Carriers of Breast Cancer-Associated Germline Pathogenic Variants in Mexico.
Fernanda Mesa-Chavez et al. JCO Glob Oncol 2024 10e2300417
Similar articles in PubMed
Medicolegal and insurance issues regarding BRCA1 and BRCA2 gene tests in high income countries.
Riccardo Oliva et al. Int J Gynecol Cancer 2024
Similar articles in PubMed
Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or Ovarian Cancer.
Sara Torres-Esquius et al. JAMA Netw Open 2024 7(4) e247811
Similar articles in PubMed
Uptake of screening and risk-reducing recommendations among women with hereditary breast and ovarian cancer syndrome due to pathogenic BRCA1/2 variants evaluated at a large urban comprehensive cancer center.
Hadeel Assad et al. Breast Cancer Res Treat 2024
Similar articles in PubMed
The Evolution of Genetic Testing from Focused Testing to Panel Testing and from Patient Focused to Population Testing: Are We There Yet?
Lauren Gima et al. Clin Colon Rectal Surg 2024 37(3) 133-139
Similar articles in PubMed
Population-based BRCA germline mutation screening in the Han Chinese identifies individuals at risk of BRCA mutation-related cancer: experience from a clinical diagnostic center from greater Shanghai area.
Zhiyuan Wu et al. BMC Cancer 2024 24(1) 411
Similar articles in PubMed
Hereditary Cancer Syndrome Carriers: Feeling Left in the Corner.
Celia Diez de Los Rios de la Serna et al. Semin Oncol Nurs 2024 151624
Similar articles in PubMed
Variants in BRCA1/2 in a hospital-based cohort in Chile and national literature review.
Fernanda J Martin et al. Ecancermedicalscience 2024 181683
Similar articles in PubMed
The BRCA mutation spectrum among breast and ovarian cancers in India: highlighting the need to screen BRCA1 185delAG among South Indians.
Ajoy Oommen John et al. Eur J Hum Genet 2024
Similar articles in PubMed
The history of families at-risk for hereditary breast and ovarian cancer: what are the impacts of genetic counseling and testing?
Natalia Campacci et al. Front Psychol 2024 151306388
Similar articles in PubMed
Clinical evaluation of a low-coverage whole-genome test for detecting homologous recombination deficiency in ovarian cancer.
Romain Boidot et al. Eur J Cancer 2024 202113978
Similar articles in PubMed
Cascade screening in HBOC and Lynch syndrome: guidelines and procedures in a UK centre.
D Gareth Evans et al. Fam Cancer 2024
Similar articles in PubMed
[Return of Individual Genomic Results to Germline Pathogenic Variant Carriers of Hereditary Cancer in Population Based Cohort Study].
Kinuko Ohneda et al. Gan To Kagaku Ryoho 2024 51(3) 231-236
Similar articles in PubMed
Delivery of hereditary cancer genetics services to patients newly diagnosed with ovarian and endometrial cancers at three gynecologic oncology clinics in the USA, Brazil, and Mexico.
Erica M Bednar et al. Int J Gynecol Cancer 2024
Similar articles in PubMed
EMQN best practice guidelines for genetic testing in hereditary breast and ovarian cancer.
Trudi McDevitt et al. Eur J Hum Genet 2024
Similar articles in PubMed
Mainstream Model of Genetic Testing for Prostate Cancer at a Large Tertiary Cancer Centre.
Xin Wang et al. Clin Genitourin Cancer 2024 102052
Similar articles in PubMed
Young Women's Perspectives on Being Screened for Hereditary Breast and Ovarian Cancer Risk During Routine Primary Care.
Mady Head et al. Womens Health Issues 2024
Similar articles in PubMed
Cancer risks among first-degree relatives of women with a genetic predisposition to breast cancer.
Qingyang Xiao et al. J Natl Cancer Inst 2024
Similar articles in PubMed
File Formats Help:
How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?
Adobe PDF file
Microsoft PowerPoint file
Microsoft Word file
Microsoft Excel file
Audio/Video file
Apple Quicktime file
RealPlayer file
Text file
Zip Archive file
SAS file
ePub file
Page last reviewed:
Feb 1, 2024
Page last updated:
May 21, 2024
Content source:
Public Health Genomics Branch in the Division of Blood Disorders and Public Health Genomics
,
National Center on Birth Defects and Developmental Disabilities
TOP